Tapewire

NYSE · USD

IQV

IQVIA HOLDINGS INC.

Export transactions ↓
Tapewire entity
3058
SEC CIK
0001478242
Parsed reports
432

Last 12 months

Inside the activity.

0 purchase rows · 10 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202501
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202607
Aug 202601
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 02, 2026 Filed Sep 4, 2026 21:00 UTC Exercise / conversionStock Appreciation Right · Derivative 5,381 $131.82 Strike: $131.82 $709,323.42
Disclosure

SEC source: 0001628280-26-060755 · wk-form4_1788555634.xml · derivative · entry 4

Berkshire James G. · CIK 0002103773 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,381 shares

Expires 2029-02-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 02, 2026 Filed Sep 4, 2026 21:00 UTC Disposition to issuerCommon Stock 2,713 $261.54 $709,558.02
Disclosure

SEC source: 0001628280-26-060755 · wk-form4_1788555634.xml · nonDerivative · entry 3

Berkshire James G. · CIK 0002103773 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,177

Read SEC document
September 02, 2026 Filed Sep 4, 2026 21:00 UTC SaleCommon Stock 2,668 $261.33 $697,228.44
Disclosure

SEC source: 0001628280-26-060755 · wk-form4_1788555634.xml · nonDerivative · entry 2

Berkshire James G. · CIK 0002103773 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,890

Read SEC document
September 02, 2026 Filed Sep 4, 2026 21:00 UTC Exercise / conversionCommon Stock 5,381 $131.82 $709,323.42
Disclosure

SEC source: 0001628280-26-060755 · wk-form4_1788555634.xml · nonDerivative · entry 1

Berkshire James G. · CIK 0002103773 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,558

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 03, 2026 Filed Aug 4, 2026 21:00 UTC
STAUB W RICHARDSee Remarks
SaleCommon Stock 5,500 $232.68 $1,279,740.00
Disclosure

SEC source: 0001628280-26-052703 · wk-form4_1785877251.xml · nonDerivative · entry 1

STAUB W RICHARD · CIK 0001181162 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,312

Read SEC document
July 31, 2026 Filed Aug 4, 2026 21:00 UTC
Patel BhavikSee Remarks
SaleCommon Stock 1,855 $235.27 $436,425.85
Disclosure

SEC source: 0001628280-26-052701 · wk-form4_1785877210.xml · nonDerivative · entry 1

Patel Bhavik · CIK 0002023629 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,348

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $235.22 to $235.29, inclusive.

Read SEC document
July 29, 2026 Filed Jul 31, 2026 21:03 UTC SaleCommon Stock 558 $245.21 $136,827.18
Disclosure

SEC source: 0001628280-26-051450 · wk-form4_1785531795.xml · nonDerivative · entry 1

Cherofsky Keriann · CIK 0001940591 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,989

Read SEC document
July 29, 2026 Filed Jul 31, 2026 21:04 UTC
Sherbet EricSee Remarks
SaleCommon Stock 5,000 $249.16 $1,245,800.00
Disclosure

SEC source: 0001628280-26-051451 · wk-form4_1785531837.xml · nonDerivative · entry 1

Sherbet Eric · CIK 0001679512 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,999

Read SEC document
July 29, 2026 Filed Jul 31, 2026 21:02 UTC
BOUSBIB ARIDirector · See Remarks
Exercise / conversionStock Appreciation Right · Derivative 156,206 $78.21 Strike: $78.21 $12,216,871.26
Disclosure

SEC source: 0001628280-26-051449 · wk-form4_1785531724.xml · derivative · entry 9

BOUSBIB ARI · CIK 0001184180 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 156,206 shares

Expires 2027-02-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 29, 2026 Filed Jul 31, 2026 21:02 UTC
BOUSBIB ARIDirector · See Remarks
Disposition to issuerCommon Stock 2,069 $247.00 $511,043.00
Disclosure

SEC source: 0001628280-26-051449 · wk-form4_1785531724.xml · nonDerivative · entry 7

BOUSBIB ARI · CIK 0001184180 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 835,941

F1 · shares: Represents the exercise of stock appreciation rights expiring on February 2, 2027.

Read SEC document
July 29, 2026 Filed Jul 31, 2026 21:02 UTC
BOUSBIB ARIDirector · See Remarks
Disposition to issuerCommon Stock 47,858 $244.60 $11,706,066.80
Disclosure

SEC source: 0001628280-26-051449 · wk-form4_1785531724.xml · nonDerivative · entry 6

BOUSBIB ARI · CIK 0001184180 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 838,010

F1 · shares: Represents the exercise of stock appreciation rights expiring on February 2, 2027.

Read SEC document
July 29, 2026 Filed Jul 31, 2026 21:02 UTC
BOUSBIB ARIDirector · See Remarks
SaleCommon Stock 53,191 $244.78 $13,020,092.98
Disclosure

SEC source: 0001628280-26-051449 · wk-form4_1785531724.xml · nonDerivative · entry 5

BOUSBIB ARI · CIK 0001184180 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 885,868

F1 · shares: Represents the exercise of stock appreciation rights expiring on February 2, 2027.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $244.60 to $245.60, inclusive.

Read SEC document
July 29, 2026 Filed Jul 31, 2026 21:02 UTC
BOUSBIB ARIDirector · See Remarks
SaleCommon Stock 44,039 $246.08 $10,837,117.12
Disclosure

SEC source: 0001628280-26-051449 · wk-form4_1785531724.xml · nonDerivative · entry 4

BOUSBIB ARI · CIK 0001184180 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 939,059

F1 · shares: Represents the exercise of stock appreciation rights expiring on February 2, 2027.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $245.70 to $246.58, inclusive.

Read SEC document
July 29, 2026 Filed Jul 31, 2026 21:02 UTC
BOUSBIB ARIDirector · See Remarks
SaleCommon Stock 4,584 $246.85 $1,131,560.40
Disclosure

SEC source: 0001628280-26-051449 · wk-form4_1785531724.xml · nonDerivative · entry 3

BOUSBIB ARI · CIK 0001184180 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 983,098

F1 · shares: Represents the exercise of stock appreciation rights expiring on February 2, 2027.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $246.70 to $247.05, inclusive.

Read SEC document
July 29, 2026 Filed Jul 31, 2026 21:02 UTC
BOUSBIB ARIDirector · See Remarks
SaleCommon Stock 4,465 $247.10 $1,103,301.50
Disclosure

SEC source: 0001628280-26-051449 · wk-form4_1785531724.xml · nonDerivative · entry 2

BOUSBIB ARI · CIK 0001184180 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 987,682

F1 · shares: Represents the exercise of stock appreciation rights expiring on February 2, 2027.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $247.00 to $247.18, inclusive.

Read SEC document
July 29, 2026 Filed Jul 31, 2026 21:02 UTC
BOUSBIB ARIDirector · See Remarks
Exercise / conversionCommon Stock 156,206 $78.21 $12,216,871.26
Disclosure

SEC source: 0001628280-26-051449 · wk-form4_1785531724.xml · nonDerivative · entry 1

BOUSBIB ARI · CIK 0001184180 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 992,147

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the exercise of stock appreciation rights expiring on February 2, 2027.

Read SEC document
July 14, 2026 Filed Jul 16, 2026 21:02 UTC GrantDeferred Shares · Derivative 160 $207.83 $33,252.80
Disclosure

SEC source: 0001628280-26-048501 · wk-form4_1784235766.xml · derivative · entry 1

DANHAKL JOHN G · CIK 0001162644 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,289

Underlying: Common Stock · 160 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

Read SEC document
July 14, 2026 Filed Jul 16, 2026 21:04 UTC GrantDeferred Shares · Derivative 148 $207.83 $30,758.84
Disclosure

SEC source: 0001628280-26-048504 · wk-form4_1784235857.xml · derivative · entry 1

Wims Morris Leslie · CIK 0001908079 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,784

Underlying: Common Stock · 148 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

Read SEC document
July 14, 2026 Filed Jul 16, 2026 21:03 UTC GrantDeferred Shares · Derivative 183 $207.83 $38,032.89
Disclosure

SEC source: 0001628280-26-048503 · wk-form4_1784235824.xml · derivative · entry 1

GOGGINS COLLEEN A · CIK 0001189008 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,297

Underlying: Common Stock · 183 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

Read SEC document
July 14, 2026 Filed Jul 16, 2026 21:03 UTC
Fasano JimDirector
GrantDeferred Shares · Derivative 195 $207.83 $40,526.85
Disclosure

SEC source: 0001628280-26-048502 · wk-form4_1784235796.xml · derivative · entry 1

Fasano Jim · CIK 0001633043 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,268

Underlying: Common Stock · 195 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

Read SEC document
May 07, 2026 Filed May 11, 2026 21:05 UTC GrantDeferred Shares · Derivative 185 $178.64 $33,048.40
Disclosure

SEC source: 0001628280-26-033650 · wk-form4_1778533546.xml · derivative · entry 1

DANHAKL JOHN G · CIK 0001162644 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,129

Underlying: Common Stock · 185 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

Read SEC document
May 07, 2026 Filed May 11, 2026 21:07 UTC GrantDeferred Shares · Derivative 171 $178.64 $30,547.44
Disclosure

SEC source: 0001628280-26-033655 · wk-form4_1778533671.xml · derivative · entry 1

Wims Morris Leslie · CIK 0001908079 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,636

Underlying: Common Stock · 171 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

Read SEC document
May 07, 2026 Filed May 11, 2026 21:07 UTC GrantDeferred Shares · Derivative 214 $178.64 $38,228.96
Disclosure

SEC source: 0001628280-26-033654 · wk-form4_1778533645.xml · derivative · entry 1

GOGGINS COLLEEN A · CIK 0001189008 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,114

Underlying: Common Stock · 214 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

Read SEC document
May 07, 2026 Filed May 11, 2026 21:06 UTC
Fasano JimDirector
GrantDeferred Shares · Derivative 228 $178.64 $40,729.92
Disclosure

SEC source: 0001628280-26-033653 · wk-form4_1778533610.xml · derivative · entry 1

Fasano Jim · CIK 0001633043 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,073

Underlying: Common Stock · 228 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

Read SEC document
April 23, 2026 Filed Apr 27, 2026 21:01 UTC GrantCommon Stock 1,571 $0.00 $0.00
Disclosure

SEC source: 0001628280-26-027604 · wk-form4_1777323689.xml · nonDerivative · entry 1

DANHAKL JOHN G · CIK 0001162644 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 30,612

F1 · shares: Shares acquired from award of IQVIA Holdings Inc. common stock for Non-Employee Directors that are fully vested upon grant.

F2 · ownership.nature: Shares held in the Danhakl Revocable Family Trust.

Read SEC document
April 23, 2026 Filed Apr 27, 2026 21:00 UTC
Burt CarolDirector
GrantCommon Stock 1,571 $0.00 $0.00
Disclosure

SEC source: 0001628280-26-027596 · wk-form4_1777323609.xml · nonDerivative · entry 1

Burt Carol · CIK 0001493926 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 7,533

F1 · shares: Shares acquired from award of IQVIA Holdings Inc. common stock for Non-Employee Directors that are fully vested upon grant.

F2 · ownership.nature: Shares held in Carol Burt Hilliard Revocable Trust.

Read SEC document
April 23, 2026 Filed Apr 27, 2026 21:04 UTC GrantDeferred Shares · Derivative 1,571 $160.68 $252,428.28
Disclosure

SEC source: 0001628280-26-027612 · wk-form4_1777323882.xml · derivative · entry 1

Stamps Sheila A · CIK 0001600782 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,210

Underlying: Common Stock · 1,571 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

Read SEC document
April 23, 2026 Filed Apr 27, 2026 21:04 UTC GrantDeferred Shares · Derivative 1,571 $160.68 $252,428.28
Disclosure

SEC source: 0001628280-26-027611 · wk-form4_1777323847.xml · derivative · entry 1

Wims Morris Leslie · CIK 0001908079 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,465

Underlying: Common Stock · 1,571 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

Read SEC document
April 23, 2026 Filed Apr 27, 2026 21:03 UTC GrantDeferred Shares · Derivative 1,571 $160.68 $252,428.28
Disclosure

SEC source: 0001628280-26-027610 · wk-form4_1777323825.xml · derivative · entry 1

Kaelin William G Jr · CIK 0001551715 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,571

Underlying: Common Stock · 1,571 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

Read SEC document
April 23, 2026 Filed Apr 27, 2026 21:03 UTC GrantCommon Stock 1,571 $0.00 $0.00
Disclosure

SEC source: 0001628280-26-027609 · wk-form4_1777323780.xml · nonDerivative · entry 1

LEONARD JOHN M · CIK 0001563584 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,946

F1 · shares: Shares acquired from award of IQVIA Holdings Inc. common stock for Non-Employee Directors that are fully vested upon grant.

Read SEC document
April 23, 2026 Filed Apr 27, 2026 21:02 UTC GrantCommon Stock 1,571 $0.00 $0.00
Disclosure

SEC source: 0001628280-26-027607 · wk-form4_1777323751.xml · nonDerivative · entry 1

GOGGINS COLLEEN A · CIK 0001189008 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,453

F1 · shares: Shares acquired from award of IQVIA Holdings Inc. common stock for Non-Employee Directors that are fully vested upon grant.

Read SEC document
April 23, 2026 Filed Apr 27, 2026 21:01 UTC
Fasano JimDirector
GrantDeferred Shares · Derivative 1,571 $160.68 $252,428.28
Disclosure

SEC source: 0001628280-26-027605 · wk-form4_1777323714.xml · derivative · entry 1

Fasano Jim · CIK 0001633043 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,845

Underlying: Common Stock · 1,571 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

Read SEC document
February 13, 2026 Filed Feb 17, 2026 22:01 UTC
Haas BerndSee Remarks
Tax withholdingCommon Stock 20 $166.94 $3,338.80
Disclosure

SEC source: 0001628280-26-008661 · wk-form4_1771365705.xml · nonDerivative · entry 1

Haas Bernd · CIK 0002104344 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,394

Read SEC document
February 13, 2026 Filed Feb 17, 2026 22:01 UTC Tax withholdingCommon Stock 123 $166.94 $20,533.62
Disclosure

SEC source: 0001628280-26-008659 · wk-form4_1771365667.xml · nonDerivative · entry 1

Fedock Michael J. · CIK 0002103784 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,472

Read SEC document
February 09, 2026 Filed Feb 11, 2026 22:08 UTC GrantStock Appreciation Right · Derivative 2,795 $0.00 Strike: $192.67 $0.00
Disclosure

SEC source: 0001628280-26-007352 · wk-form4_1770847730.xml · derivative · entry 1

Cherofsky Keriann · CIK 0001940591 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,795

Underlying: Common Stock · 2,795 shares

Expires 2036-02-09

F1 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on February 9, 2027.

Read SEC document
February 09, 2026 Filed Feb 11, 2026 22:05 UTC GrantDeferred Shares · Derivative 172 $192.67 $33,139.24
Disclosure

SEC source: 0001628280-26-007344 · wk-form4_1770847554.xml · derivative · entry 1

DANHAKL JOHN G · CIK 0001162644 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,944

Underlying: Common Stock · 172 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

Read SEC document
February 09, 2026 Filed Feb 11, 2026 22:10 UTC
Patel BhavikSee Remarks
GrantStock Appreciation Right · Derivative 11,180 $0.00 Strike: $192.67 $0.00
Disclosure

SEC source: 0001628280-26-007356 · wk-form4_1770847849.xml · derivative · entry 1

Patel Bhavik · CIK 0002023629 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,180

Underlying: Common Stock · 11,180 shares

Expires 2036-02-09

F1 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on February 9, 2027.

Read SEC document
February 09, 2026 Filed Feb 11, 2026 22:11 UTC
STAUB W RICHARDSee Remarks
GrantStock Appreciation Right · Derivative 26,088 $0.00 Strike: $192.67 $0.00
Disclosure

SEC source: 0001628280-26-007358 · wk-form4_1770847901.xml · derivative · entry 1

STAUB W RICHARD · CIK 0001181162 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,088

Underlying: Common Stock · 26,088 shares

Expires 2036-02-09

F1 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on February 9, 2027.

Read SEC document
February 09, 2026 Filed Feb 11, 2026 22:11 UTC
Sherbet EricSee Remarks
GrantStock Appreciation Right · Derivative 12,112 $0.00 Strike: $192.67 $0.00
Disclosure

SEC source: 0001628280-26-007357 · wk-form4_1770847877.xml · derivative · entry 1

Sherbet Eric · CIK 0001679512 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,112

Underlying: Common Stock · 12,112 shares

Expires 2036-02-09

F1 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on February 9, 2027.

Read SEC document
February 09, 2026 Filed Feb 11, 2026 22:10 UTC
Haas BerndSee Remarks
GrantStock Appreciation Right · Derivative 11,180 $0.00 Strike: $192.67 $0.00
Disclosure

SEC source: 0001628280-26-007355 · wk-form4_1770847826.xml · derivative · entry 1

Haas Bernd · CIK 0002104344 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,180

Underlying: Common Stock · 11,180 shares

Expires 2036-02-09

F1 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on February 9, 2027.

Read SEC document
February 09, 2026 Filed Feb 11, 2026 22:10 UTC GrantStock Appreciation Right · Derivative 26,088 $0.00 Strike: $192.67 $0.00
Disclosure

SEC source: 0001628280-26-007354 · wk-form4_1770847801.xml · derivative · entry 1

Grenfell Alistair · CIK 0002104640 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,088

Underlying: Common Stock · 26,088 shares

Expires 2036-02-09

F1 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on February 9, 2027.

Read SEC document
February 09, 2026 Filed Feb 11, 2026 22:09 UTC GrantStock Appreciation Right · Derivative 18,634 $0.00 Strike: $192.67 $0.00
Disclosure

SEC source: 0001628280-26-007353 · wk-form4_1770847762.xml · derivative · entry 1

Fedock Michael J. · CIK 0002103784 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,634

Underlying: Common Stock · 18,634 shares

Expires 2036-02-09

F1 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on February 9, 2027.

Read SEC document
February 09, 2026 Filed Feb 11, 2026 22:08 UTC GrantStock Appreciation Right · Derivative 11,180 $0.00 Strike: $192.67 $0.00
Disclosure

SEC source: 0001628280-26-007350 · wk-form4_1770847705.xml · derivative · entry 1

Berkshire James G. · CIK 0002103773 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,180

Underlying: Common Stock · 11,180 shares

Expires 2036-02-09

F1 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on February 9, 2027.

Read SEC document
February 09, 2026 Filed Feb 11, 2026 22:08 UTC
BOUSBIB ARIDirector · See Remarks
GrantStock Appreciation Right · Derivative 78,264 $0.00 Strike: $192.67 $0.00
Disclosure

SEC source: 0001628280-26-007349 · wk-form4_1770847681.xml · derivative · entry 1

BOUSBIB ARI · CIK 0001184180 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 78,264

Underlying: Common Stock · 78,264 shares

Expires 2036-02-09

F1 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on February 9, 2027.

Read SEC document
February 09, 2026 Filed Feb 11, 2026 22:07 UTC GrantDeferred Shares · Derivative 159 $192.67 $30,634.53
Disclosure

SEC source: 0001628280-26-007348 · wk-form4_1770847634.xml · derivative · entry 1

Wims Morris Leslie · CIK 0001908079 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,894

Underlying: Common Stock · 159 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

Read SEC document
February 09, 2026 Filed Feb 11, 2026 22:06 UTC GrantDeferred Shares · Derivative 198 $192.67 $38,148.66
Disclosure

SEC source: 0001628280-26-007347 · wk-form4_1770847610.xml · derivative · entry 1

GOGGINS COLLEEN A · CIK 0001189008 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,900

Underlying: Common Stock · 198 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

Read SEC document
February 09, 2026 Filed Feb 11, 2026 22:06 UTC
Fasano JimDirector
GrantDeferred Shares · Derivative 211 $192.67 $40,653.37
Disclosure

SEC source: 0001628280-26-007346 · wk-form4_1770847585.xml · derivative · entry 1

Fasano Jim · CIK 0001633043 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,274

Underlying: Common Stock · 211 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

Read SEC document
February 08, 2026 Filed Feb 10, 2026 22:46 UTC Tax withholdingCommon Stock 415 $187.49 $77,808.35
Disclosure

SEC source: 0001628280-26-006955 · wk-form4_1770763581.xml · nonDerivative · entry 2

Cherofsky Keriann · CIK 0001940591 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,547

Read SEC document
February 08, 2026 Filed Feb 10, 2026 22:46 UTC GrantCommon Stock 1,087 $0.00 $0.00
Disclosure

SEC source: 0001628280-26-006955 · wk-form4_1770763581.xml · nonDerivative · entry 1

Cherofsky Keriann · CIK 0001940591 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,962

F1 · shares: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 13, 2023. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on February 8, 2026.

Read SEC document
February 08, 2026 Filed Feb 10, 2026 22:50 UTC
Patel BhavikSee Remarks
Tax withholdingCommon Stock 1,920 $187.49 $359,980.80
Disclosure

SEC source: 0001628280-26-006964 · wk-form4_1770763843.xml · nonDerivative · entry 2

Patel Bhavik · CIK 0002023629 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,203

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.